DE69023163D1 - Natriumhyaluronat-Zusammensetzung. - Google Patents
Natriumhyaluronat-Zusammensetzung.Info
- Publication number
- DE69023163D1 DE69023163D1 DE69023163T DE69023163T DE69023163D1 DE 69023163 D1 DE69023163 D1 DE 69023163D1 DE 69023163 T DE69023163 T DE 69023163T DE 69023163 T DE69023163 T DE 69023163T DE 69023163 D1 DE69023163 D1 DE 69023163D1
- Authority
- DE
- Germany
- Prior art keywords
- sodium hyaluronate
- hyaluronate composition
- hyaluronate
- composition
- opthalamological
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/194,187 US4920104A (en) | 1988-05-16 | 1988-05-16 | Sodium hyaluronate composition |
CA002011956A CA2011956C (en) | 1988-05-16 | 1990-03-12 | Sodium hyaluronate composition |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69023163D1 true DE69023163D1 (de) | 1995-11-30 |
DE69023163T2 DE69023163T2 (de) | 1996-06-27 |
Family
ID=25674005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69023163T Expired - Lifetime DE69023163T2 (de) | 1988-05-16 | 1990-03-12 | Natriumhyaluronat-Zusammensetzung. |
Country Status (6)
Country | Link |
---|---|
US (1) | US4920104A (de) |
EP (1) | EP0399156B1 (de) |
JP (1) | JP3065327B2 (de) |
AT (1) | ATE129411T1 (de) |
CA (1) | CA2011956C (de) |
DE (1) | DE69023163T2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2146200T3 (es) * | 1990-02-13 | 2000-08-01 | Ethicon Inc | Medicamentos inducidos peritonealmente. |
IT1247175B (it) * | 1991-04-19 | 1994-12-12 | Fidia Spa | Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico. |
US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
IT1254712B (it) * | 1992-01-20 | 1995-10-09 | Uso dell'acido ialuronico lubrificante di protesi oculari. | |
US5612027A (en) * | 1995-04-18 | 1997-03-18 | Galin; Miles A. | Controlled release of miotic and mydriatic drugs in the anterior chamber |
IT1277707B1 (it) * | 1995-12-22 | 1997-11-11 | Chemedica Sa | Formulazione oftalmica a base di ialuronato di sodio per uso nella chirurgia oculare |
US6541460B2 (en) | 1996-08-07 | 2003-04-01 | George D. Petito | Method for use of hyaluronic acid in wound management |
AU723614B2 (en) * | 1997-02-13 | 2000-08-31 | Bausch & Lomb Surgical, Inc. | Method for destroying retinal pigment epithelial cells |
SE9700827D0 (sv) * | 1997-03-07 | 1997-03-07 | Pharmacia & Upjohn Ab | Ophthalmic composition |
US6368585B1 (en) | 1997-03-25 | 2002-04-09 | Pharmacia Ab | Opthalmic compositions and methods |
US6638917B1 (en) | 2000-02-25 | 2003-10-28 | Scimed Life Systems, Inc. | Reducing adhesion |
US7820194B2 (en) * | 2001-12-21 | 2010-10-26 | Alcon, Inc. | Combinations of viscoelastics for use during surgery |
US20040101561A1 (en) * | 2002-11-13 | 2004-05-27 | Jafari Masoud R. | Combinations of viscoelastics for use during surgery |
BR0309890A (pt) * | 2002-05-09 | 2005-05-10 | Medigenes | Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação |
AU2003256381A1 (en) * | 2002-07-03 | 2004-01-23 | Pericor Science, Inc | Compositions of hyaluronic acid and methods of use |
US20040167480A1 (en) * | 2003-02-21 | 2004-08-26 | Advanced Medical Optics, Inc. | Administration of multiple viscoelastic solutions with a multi-compartment syringe |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
US20050250737A1 (en) * | 2003-11-12 | 2005-11-10 | Allergan, Inc. | Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
US20060141049A1 (en) * | 2003-11-12 | 2006-06-29 | Allergan, Inc. | Triamcinolone compositions for intravitreal administration to treat ocular conditions |
JP2007518804A (ja) | 2004-01-20 | 2007-07-12 | アラーガン、インコーポレイテッド | トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物 |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US8147865B2 (en) * | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
WO2006017347A2 (en) * | 2004-07-12 | 2006-02-16 | Allergan, Inc. | Opthalmic compositions and methods for treating ophthalmic conditions |
US20060159651A1 (en) * | 2005-01-14 | 2006-07-20 | Michael Colvard | Gradient molecular weight viscoelastic solutions |
US7323184B2 (en) * | 2005-08-22 | 2008-01-29 | Healagenics, Inc. | Compositions and methods for the treatment of wounds and the reduction of scar formation |
US8668676B2 (en) * | 2006-06-19 | 2014-03-11 | Allergan, Inc. | Apparatus and methods for implanting particulate ocular implants |
US9039761B2 (en) | 2006-08-04 | 2015-05-26 | Allergan, Inc. | Ocular implant delivery assemblies with distal caps |
US8545554B2 (en) * | 2009-01-16 | 2013-10-01 | Allergan, Inc. | Intraocular injector |
WO2011057275A2 (en) * | 2009-11-09 | 2011-05-12 | Arizona Board of Regents, a body corporate acting for and on behalf of Arizona State University | Molecular films for hydrophobic implant surfaces |
IT1402382B1 (it) | 2010-09-09 | 2013-09-04 | Ibsa Inst Biochimique Sa | Complessi cooperativi ibridi di acido ialuronico |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US4328803B1 (en) * | 1980-10-20 | 1994-01-11 | Opthalmic Systems, Inc. | Opthalmological procedures |
SE442820B (sv) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut |
US4713375A (en) * | 1985-08-01 | 1987-12-15 | Lindstrom Richard L | Viscoelastic solution |
-
1988
- 1988-05-16 US US07/194,187 patent/US4920104A/en not_active Expired - Lifetime
-
1990
- 1990-03-12 DE DE69023163T patent/DE69023163T2/de not_active Expired - Lifetime
- 1990-03-12 AT AT90104673T patent/ATE129411T1/de not_active IP Right Cessation
- 1990-03-12 EP EP90104673A patent/EP0399156B1/de not_active Expired - Lifetime
- 1990-03-12 CA CA002011956A patent/CA2011956C/en not_active Expired - Lifetime
- 1990-03-16 JP JP02064472A patent/JP3065327B2/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
ATE129411T1 (de) | 1995-11-15 |
CA2011956A1 (en) | 1991-09-12 |
JPH03271228A (ja) | 1991-12-03 |
CA2011956C (en) | 1998-02-03 |
DE69023163T2 (de) | 1996-06-27 |
EP0399156A1 (de) | 1990-11-28 |
EP0399156B1 (de) | 1995-10-25 |
JP3065327B2 (ja) | 2000-07-17 |
US4920104A (en) | 1990-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE129411T1 (de) | Natriumhyaluronat-zusammensetzung. | |
AU5841090A (en) | Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same | |
EP1154287A3 (de) | Sauerstoffdurchlässige Kontaktlinse mit hydrophiler Oberfläche und Verfahren zur Herstellung derselben | |
ATE233083T1 (de) | Synthetisches viskoseelastisches material für physiologische anwendungen wie für ophtalmologische anwendungen | |
SE9101957D0 (sv) | Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma | |
DK0781547T3 (da) | Ophthalmisk formulering baseret på natriumhyaluronat til anvendelse i øjen-kirugi | |
DE69013833T2 (de) | Zusammensetzung und methode zur verhütung von verklebungen zwischen körpergewebe. | |
KR890004720A (ko) | 성장 인자를 함유하는 겔 제형 | |
KR890011918A (ko) | 개선된 의료용 폴리(프로필렌 글리콜 푸마레이트)조성물 | |
ATE153346T1 (de) | Oxidationsresistente analoga des thrombomodulins | |
ATE309693T1 (de) | Zusammensetzungen enthaltend heparin mit niedrigem molekülargewicht | |
IT1290814B1 (it) | Glicosaminoglicani aventi elevata attivita' antitrombotica | |
BR9708502A (pt) | Fluido de estocagem corneal compreendido por ácido hialurônico | |
CA2282757A1 (en) | Opthalmic composition | |
AU6243601A (en) | Use a high-molecular-weight extracellular haemoglobin as blood substitute | |
MX9701609A (es) | Composicion espesada por un alquileter de polisacarido. | |
ATE325828T1 (de) | Polymerträger mit polyoxalkylenen | |
FI934902A0 (fi) | Genetisk kontroll av acetylening och puryvylening av xantan baserade polysackaridpolymerer | |
BR0115154A (pt) | material viscoelástico transicional não-aspirante para uso em cirurgia | |
IT1254712B (it) | Uso dell'acido ialuronico lubrificante di protesi oculari. | |
ATE183103T1 (de) | Resorbierbare knochendichtungsmittel | |
CA2086188A1 (en) | Use of hyaluronic acid as ocular prosthesis lubricant | |
RU94005436A (ru) | Эндопротез сустава пальца кисти | |
TH10169A (th) | สารผสมสำหรับเครื่องสำอาง | |
ES8307867A1 (es) | "un procedimiento para preparar hidrogeles que retienen la forma a base de colageno solubilizado, utiles por ejemplo para fines medicos y cosmeticos". |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: CHIRON VISION CORP., CLAREMONT, CALIF., US |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: BAUSCH & LOMB SURGICAL, INC., CLAREMONT, CALIF., U |